| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Bernstein analyst Peter Weed maintains Atlassian (NASDAQ:TEAM) with a Outperform and raises the price target from $290 to $304.
Macquarie analyst Steve Koenig maintains Atlassian (NASDAQ:TEAM) with a Outperform and lowers the price target from $250 to ...
Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap gi...
Bernstein analyst Peter Weed maintains Atlassian (NASDAQ:TEAM) with a Outperform and lowers the price target from $296 to $290.
Mizuho analyst Gregg Moskowitz maintains Atlassian (NASDAQ:TEAM) with a Outperform and raises the price target from $235 to ...
Atlassian announces financial results for the first quarter of fiscal 2026 after the bell on Thursday. Here's a rundown of ...
-SEC Filing
Atlassian (NASDAQ:TEAM) sees Q2 sales of $1.535 billion-$1.543 billion vs $1.514 billion analyst estimate.